Sat, Jul 26, 2014, 2:08 AM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Neurocrine Biosciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • frogsleapmerlot frogsleapmerlot Oct 19, 2010 10:42 AM Flag

    VMAT Inhibitor moving into P2 trials

    The fallen Angle status is gone

    The street is starting to fall in ♥ with NBIX and that is very very good for supporting a higher stock price.

    When NBIX announces that P3 E has started for Endo and P2 for UF.

    We go to double digits,,

    Again this stock is going to get valued like Vertex has gotten valued on its HepC inhibitor. huge MKT OPP and no good treatment options.


13.53-0.14(-1.02%)Jul 25 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.